Who owns the TRINOMAB trademark?

The TRINOMAB trademark is owned by Zhuhai Trinomab Pharmaceutical Co., Ltd..

What is the serial number for TRINOMAB?

The USPTO serial number for TRINOMAB is 79350028.

What is the registration number for TRINOMAB?

TRINOMAB is registered under USPTO registration number 7470062.

TRI

USPTO Trademark Record

REGISTERED

TRINOMAB

Q: What class is the TRINOMAB trademark registered in?

The TRINOMAB trademark is registered in Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

SN 79350028·Reg 7470062·Filed Jul 12, 2022

Owner Zhuhai Trinomab Pharmaceutical Co., Ltd.

Advertising; business management, organization and administration; office functions.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

TRINOMAB (Serial No. 79350028), Registration No. 7470062, is a registered US trademark filed on Jul 12, 2022 by Zhuhai Trinomab Pharmaceutical Co., Ltd.. This trademark covers Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

early section 8: August 13, 2030

Mark Intelligence

TRINOMAB (Reg. #7470062) is a registered US trademark that has been protecting its owner, Zhuhai Trinomab Pharmaceutical Co., Ltd., since 2022. The mark covers Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Advertising; business management, organization and administration; office functions.; Scientific and technological servi.... The mark faced 6 opposition proceedings during prosecution.

FILED

Jul 12, 2022

SERIAL

79350028

REG#

7470062

REGISTERED

Aug 13, 2024

Owner

Applicant

Zhuhai Trinomab Pharmaceutical Co., Ltd.

Entity

Not Provided

Address

Rm.110, 1/F., Plant Building 6,, No.6366 Zhuhai Avenue, Jinwan District, Zhuhai City, Guangdong

Country

Attorney

NameScot A. Duvall

Law firm

Scot A. Duvall STITES & HARBISON PLLC

Docket

101436230000

Address

250 W. Main Street, Suite 2300, Lexington, KY 40507, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJul 12, 2022

Serial Number79350028

Registration No.7470062

Registration DateAug 13, 2024

Status DateAug 13, 2024

Published for OppositionMay 28, 2024

Mark TypeDesign with words

Attorney Docket101436230000

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 6× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

44 events

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Dec 24, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Dec 24, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Dec 24, 2025

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Dec 24, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Dec 24, 2025

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

FINAL DECISION TRANSACTION PROCESSED BY IB

Mar 29, 2025

FINAL DECISION TRANSACTION PROCESSED BY IB

GENERIC MADRID TRANSACTION CREATED

Feb 01, 2025

GENERIC MADRID TRANSACTION CREATED

GENERIC MADRID TRANSACTION SENT TO IB

Feb 01, 2025

GENERIC MADRID TRANSACTION SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Nov 13, 2024

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Aug 13, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 13, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTIFICATION PROCESSED BY IB

Jun 11, 2024

NOTIFICATION PROCESSED BY IB

PUBLISHED FOR OPPOSITION

May 28, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 28, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

May 15, 2024

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

May 15, 2024

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 08, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Apr 24, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Apr 24, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 24, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Apr 24, 2024

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 24, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Mar 11, 2024

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Feb 21, 2024

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Feb 21, 2024

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

FINAL REFUSAL WRITTEN

Oct 11, 2023

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Oct 11, 2023

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Oct 11, 2023

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 02, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 30, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 30, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

CHANGE OF NAME/ADDRESS REC'D FROM IB

Sep 22, 2023

CHANGE OF NAME/ADDRESS REC'D FROM IB

REFUSAL PROCESSED BY IB

Jul 22, 2023

REFUSAL PROCESSED BY IB

ATTORNEY REVIEW COMPLETED

Jun 30, 2023

ATTORNEY REVIEW COMPLETED

REFUSAL PROCESSED BY MPU

Jun 28, 2023

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jun 28, 2023

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

Jun 27, 2023

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

LIMITATION OF GOODS RECEIVED FROM IB

Jun 10, 2023

LIMITATION OF GOODS RECEIVED FROM IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Apr 29, 2023

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Apr 28, 2023

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Apr 26, 2023

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Sep 23, 2022

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 19, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Sep 16, 2022

SN ASSIGNED FOR SECT 66A APPL FROM IB

TRINOMAB

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Zhuhai Trinomab Pharmaceutical Co., Ltd.

Other Marks by Scot A. Duvall

Resources

Company